Evidence map›Paper›PMID 42553098›Full record

ArticleFrontiers in endocrinology2026

Phantom-based evaluation of radiomics feature stability for low-dose CT lung cancer screening.

Sunyi Zheng, Xiaomeng Yang, Hongren Wang, Zhipeng Gao, Pengchun Ye, Weiping Wang, Wenhua Li, Donghua Meng, Shuai Zhang, Wenjia Zhang and 6 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sunyi Zheng *Department of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Xiaomeng Yang *Department of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Hongren Wang *Department of Radiology, Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, China.
Zhipeng GaoDepartment of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Pengchun YeDepartment of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Weiping WangAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
Wenhua LiDepartment of Radiology, Ordos Central Hospital, Ordos, China.
Donghua MengDepartment of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Shuai ZhangDepartment of Public Health, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands.
Wenjia ZhangDepartment of Radiology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Houpu LiuDepartment of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Shuyuan HuangDepartment of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Chunlin ZhangDepartment of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Jing WangSchool of Public Health, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Jihui HaoPancreas Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Xiaonan CuiDepartment of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of Digestive Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the stability of radiomic features derived from lung nodules under low-dose CT lung cancer screening conditions and to evaluate the influence of feature stability on model performance. Methods: A chest phantom containing eight simulated lung nodules was scanned on five CT scanners using varying tube voltages (100-120 kVp) and tube currents (20-60 mA·s) to simulate inter-scanner and intra-scanner variability. Nodule radiomic features were extracted accordingly and their stability was evaluated using the intraclass correlation coefficient. Stable features were grouped by hierarchical clustering, from which representative stable features were selected for each cluster. Models constructed using representative stable features and remaining unstable features were compared in two independent lung cancer screening datasets for nodule malignancy assessment and growth prediction. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). Results: Inter-scanner variability had a greater impact on feature stability than intra-scanner variability, with tube current exerting more influence than tube voltage. Models based on representative stable features achieved better performance than those using unstable features in both the malignancy assessment cohort (AUC, 0.995 vs 0.945) and nodule growth prediction cohort (AUC, 0.799 vs 0.610). Models using representative stable features also showed smaller performance differences between training and test sets than those using unstable features. Conclusion: Radiomic features with high stability under lung cancer screening conditions were associated with improved performance consistency in independent screening datasets. These findings suggest stability-informed feature selection may contribute to more reliable radiomics applications in lung cancer screening.

Indexed as

Early Detection of CancerLung NeoplasmsPhantoms, ImagingRadiomicsTomography, X-Ray ComputedHumansRadiation Dosagecomputed tomographyfeature stabilitylung cancer screeningphantomradiomics

Identifiers

PMID42553098
PMCPMC13433243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.